Trajectories of function and biomarkers with age: the CHS All Stars Study

Anne B. Newman, Jason L. Sanders, Jorge Kizer, Robert M. Boudreau, Michelle C. Odden, Adina Zeki Al Hazzouri, Alice M. Arnold

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BACKGROUND: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.

METHODS: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.

RESULTS: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.

CONCLUSIONS: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.

Original languageEnglish (US)
Pages (from-to)1135-1145
Number of pages11
JournalInternational Journal of Epidemiology
Volume45
Issue number4
StatePublished - Aug 1 2016

Fingerprint

Cystatin C
Hand Strength
Biomarkers
Health Status
Interleukin-6
Dehydroepiandrosterone Sulfate
Adiponectin
Health
Growth Hormone
Adiposity
Insulin-Like Growth Factor I
Comorbidity
Chronic Disease
Steroids
Insulin
Inflammation
Kidney
Walking Speed

Keywords

  • Ageing
  • biomarkers
  • cognitive function
  • disability
  • gait speed
  • grip strength

ASJC Scopus subject areas

  • Epidemiology

Cite this

Newman, A. B., Sanders, J. L., Kizer, J., Boudreau, R. M., Odden, M. C., Zeki Al Hazzouri, A., & Arnold, A. M. (2016). Trajectories of function and biomarkers with age: the CHS All Stars Study. International Journal of Epidemiology, 45(4), 1135-1145.

Trajectories of function and biomarkers with age : the CHS All Stars Study. / Newman, Anne B.; Sanders, Jason L.; Kizer, Jorge; Boudreau, Robert M.; Odden, Michelle C.; Zeki Al Hazzouri, Adina; Arnold, Alice M.

In: International Journal of Epidemiology, Vol. 45, No. 4, 01.08.2016, p. 1135-1145.

Research output: Contribution to journalArticle

Newman, AB, Sanders, JL, Kizer, J, Boudreau, RM, Odden, MC, Zeki Al Hazzouri, A & Arnold, AM 2016, 'Trajectories of function and biomarkers with age: the CHS All Stars Study', International Journal of Epidemiology, vol. 45, no. 4, pp. 1135-1145.
Newman AB, Sanders JL, Kizer J, Boudreau RM, Odden MC, Zeki Al Hazzouri A et al. Trajectories of function and biomarkers with age: the CHS All Stars Study. International Journal of Epidemiology. 2016 Aug 1;45(4):1135-1145.
Newman, Anne B. ; Sanders, Jason L. ; Kizer, Jorge ; Boudreau, Robert M. ; Odden, Michelle C. ; Zeki Al Hazzouri, Adina ; Arnold, Alice M. / Trajectories of function and biomarkers with age : the CHS All Stars Study. In: International Journal of Epidemiology. 2016 ; Vol. 45, No. 4. pp. 1135-1145.
@article{3d94e5d3a5a34bbc8a51972e22d77ec7,
title = "Trajectories of function and biomarkers with age: the CHS All Stars Study",
abstract = "BACKGROUND: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.METHODS: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.RESULTS: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.CONCLUSIONS: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.",
keywords = "Ageing, biomarkers, cognitive function, disability, gait speed, grip strength",
author = "Newman, {Anne B.} and Sanders, {Jason L.} and Jorge Kizer and Boudreau, {Robert M.} and Odden, {Michelle C.} and {Zeki Al Hazzouri}, Adina and Arnold, {Alice M.}",
year = "2016",
month = "8",
day = "1",
language = "English (US)",
volume = "45",
pages = "1135--1145",
journal = "International Journal of Epidemiology",
issn = "0300-5771",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Trajectories of function and biomarkers with age

T2 - the CHS All Stars Study

AU - Newman, Anne B.

AU - Sanders, Jason L.

AU - Kizer, Jorge

AU - Boudreau, Robert M.

AU - Odden, Michelle C.

AU - Zeki Al Hazzouri, Adina

AU - Arnold, Alice M.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - BACKGROUND: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.METHODS: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.RESULTS: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.CONCLUSIONS: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.

AB - BACKGROUND: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.METHODS: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.RESULTS: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.CONCLUSIONS: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.

KW - Ageing

KW - biomarkers

KW - cognitive function

KW - disability

KW - gait speed

KW - grip strength

UR - http://www.scopus.com/inward/record.url?scp=85014417215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014417215&partnerID=8YFLogxK

M3 - Article

C2 - 27272182

AN - SCOPUS:85014417215

VL - 45

SP - 1135

EP - 1145

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

SN - 0300-5771

IS - 4

ER -